VARIANT ADENO-ASSOCIATED VIRUS (AAV)CAPSID POLYPEPTIDES AND GENE THERAPEUTICS THEREOF FOR TREATMENT OF HEARING LOSS

Described herein are variant adeno-associated virus (AAV) capsid polypeptides and gene therapeutics thereof for use in the treatment or prevention of hearing loss. En la presente se describen polipéptidos de la cápside variante del virus adenoasociado (AAV) y su terapéutica génica para usar en el tr...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	PENNOCK Steven, WANG Xiaobo, FOSTER Alan, C, TIMMERS Adrian, M, PIU Fabrice, MATHUR Pranav, Dinesh, URIBE Phillip, M, SZOBOTA Stephanie, SHEARMAN Mark, BARTOLOME Christopher, JACQUES Bonnie, E
Format:	Patent
Sprache:	eng ; spa
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Described herein are variant adeno-associated virus (AAV) capsid polypeptides and gene therapeutics thereof for use in the treatment or prevention of hearing loss. En la presente se describen polipéptidos de la cápside variante del virus adenoasociado (AAV) y su terapéutica génica para usar en el tratamiento o la prevención de la pérdida de audición.